Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-ANGPTL3 antibodies suitable for high concentration compositions and subcutaneous administration

Anti-ANGPTL3 antibodies suitable for high concentration compositions and subcutaneous administration

US Patent 11780910 · Granted Oct 10, 2023

Estimated economic value: $148,406,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti IL-6 domain antibodies with fatty acid substituents2025
Site directed mutagenesis of TREM-1 antibodies for decreasing viscosity2024
Highly potent ISVD compounds capable of substituting for FVIII(A)2024
Highly potent ISVD compounds capable of substituting for FVIII(A)2024
Procoagulant antibodies2024
Nucleic acids encoding antibodies that bind and block triggering receptor expres2024
Procoagulant antibodies2022
Site directed mutagenesis of TREM-1 antibodies for decreasing viscosity2021
Methods of treating autoimmune disease or chronic inflammation with antibodies t2021
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 2019
Site directed mutagenesis of TREM-1 antibodies for decreasing viscosity2019
Targeting tissue factor to activated platelets2018